The continued EGFR-TKI with cytotoxic chemotherapy at progression-poison or medicine?

Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S176-S178. doi: 10.21037/tlcr.2018.03.23.

Authors

Shin-Kyo Yoon¹, Chang Min Choi^{1

2}, Jae Cheol Lee¹

Affiliations

¹ Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
² Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

No abstract available

Publication types

Editorial
Comment